证券代码：603948 证券简称：建业股份 公告编号：2025-025 浙江建业化工股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 浙江建业化工股份有限公司（以下简称"公司"）股票于 2025 年 11 月 13 日、11 月 14 日连续两个交易日收盘价格涨幅偏离值累计超过 20%。根据《上 海证券交易所交易规则》的相关规定，属于股票交易异常波动情形。 经公司自查及发函问询控股股东、实际控制人，截至本公告披露日，公 司生产经营正常，不存在应披露而未披露的重大信息。 一、股票交易异常波动的具体情况 公司股票于 2025 年 11 月 13 日、11 月 14 日连续两个交易日收盘价格涨幅 偏离值累计超过 20%。根据《上海证券交易所交易规则》的相关规定，属于股票 交易异常波动情形。 1 经营秩序正常。 （二）重大事项情况。经公司自查，并向公司控股股东、实际控制人核实， 截至本公告披露日，公司及控股股东、实际控制人均不存在应披露而未披露的重 大信息，包括但不限于重大资产重 ...

Core Insights - The solar energy sector in the A-share market is experiencing significant growth, with multiple stocks reaching their daily limit up [1] - China is a major contributor to global electricity growth, with approximately three-quarters of new electricity supply coming from solar energy [1] - Elon Musk has highlighted solar power as potentially the largest energy source for human civilization to date [1] Company Performance - Top performing solar stocks include: - **拓日新能 (TuoRi New Energy)**: Increased by 10.05%, market cap of 6.811 billion [2] - **日出东方 (Rising Sun Oriental)**: Increased by 10.04%, market cap of 9 billion [2] - **锡装股份 (XiZhuang Co.)**: Increased by 10.01%, market cap of 6.583 billion [2] - **捷荣技术 (JieRong Technology)**: Increased by 10.00%, market cap of 4.798 billion [2] - **建业股份 (JianYe Co.)**: Increased by 10.00%, market cap of 5.525 billion [2] - **清源股份 (QingYuan Co.)**: Increased by 9.99%, market cap of 4.299 billion [2] - **国晟科技 (GuoSheng Technology)**: Increased by 9.96%, market cap of 5.581 billion [2] - **电投产融 (DianTou ChanRong)**: Increased by 9.94%, market cap of 39.3 billion [2] - **永泰能源 (YongTai Energy)**: Increased by 9.82%, market cap of 39.1 billion [2] - **弘元绿能 (HongYuan Green Energy)**: Increased by 9.23%, market cap of 26.1 billion [2] - **昱能科技 (YuNeng Technology)**: Increased by 9.08%, market cap of 10.5 billion [2] - **上能电气 (ShangNeng Electric)**: Increased by 9.05%, market cap of 24.5 billion [2] - **TCL中环 (TCL ZhongHuan)**: Increased by 7.88%, market cap of 45.9 billion [2] - **隆基绿能 (Longi Green Energy)**: Increased by 7.89%, market cap of 174.1 billion [2] - **时创能源 (ShiChuang Energy)**: Increased by 7.63%, market cap of 7.108 billion [2] Electricity Generation Trends - Data indicates a significant increase in electricity generation, with solar energy being a key driver in China compared to other sources [3]

Core Insights - The company reported a total revenue of 1.564 billion, a decrease of 214 million compared to the same period last year, representing a year-on-year decline of 12.04% [1] - The net profit attributable to shareholders was 176 million, with net cash inflow from operating activities amounting to 293 million [1] Financial Metrics - The latest debt-to-asset ratio stands at 18.17% [3] - The gross profit margin is 17.37%, down by 0.44 percentage points from the previous quarter [3] - Return on equity (ROE) is reported at 8.37% [3] - The diluted earnings per share (EPS) is 1.08 [3] - Total asset turnover ratio is 0.61 times, a decrease of 0.06 times compared to the same period last year, reflecting a year-on-year decline of 9.66% [3] - Inventory turnover ratio is 10.22 times [3] Shareholder Information - The number of shareholders is 15,200, with the top ten shareholders holding a total of 122 million shares, accounting for 74.92% of the total share capital [3] - The top shareholders include: - Feng Yuhang: 24.8% - Zhao Qian: 24.8% - Jiande State-owned Assets Management Co., Ltd.: 20.81% - Jiande Jianye Investment Consulting Co., Ltd.: 1.69% - Jiande Jianyi Investment Consulting Partnership (Limited Partnership): 0.55% - Qian Xiaoxia: 0.50% - Yang Xianlin: 0.49% - Wang Yousi: 0.45% - Chen Aihua: 0.40% - Goldman Sachs LLC: 0.35% [3]

Core Insights - The company reported a revenue of 506,397,437.08 yuan for Q3 2025, representing a year-on-year decline of 13.33% [1] - The net profit attributable to shareholders of the listed company was 57,489,621.67 yuan, showing a year-on-year increase of 56.26% [1] Financial Performance - Revenue for Q3 2025: 506.4 million yuan, down 13.33% compared to the previous year [1] - Net profit for Q3 2025: 57.5 million yuan, up 56.26% year-on-year [1]

Core Insights - The company reported a revenue of 1.564 billion yuan for the first three quarters of 2025, representing a year-on-year decline of 12.04% [1] - The net profit attributable to shareholders reached 176 million yuan, showing a year-on-year increase of 5.66% [1] - The net profit excluding non-recurring items was 167 million yuan, reflecting a year-on-year growth of 9.05% [1] - The basic earnings per share stood at 1.08 yuan [1]

Core Viewpoint - Jianye Co., Ltd. reported a decline in revenue for Q3 2025, while net profit showed significant growth, indicating a mixed performance in financial results [1] Financial Performance - Q3 revenue was 506 million yuan, a year-on-year decrease of 13.33% [1] - Q3 net profit reached 57.49 million yuan, a year-on-year increase of 56.26% [1] - Revenue for the first three quarters was 1.564 billion yuan, down 12.04% year-on-year [1] - Net profit for the first three quarters was 176 million yuan, reflecting a year-on-year growth of 5.66% [1] - Basic earnings per share stood at 1.08 yuan [1] Product Margin - The gross margin for the company's main products increased year-on-year during Q3 [1]

Group 1 - The core point of the article is that Jianye Co., Ltd. held its 14th meeting of the 5th Board of Directors on October 24, 2025, to review the proposal regarding the company's Q3 2025 report [1] - For the year 2024, Jianye Co., Ltd.'s revenue composition is 95.88% from the chemical industry and 4.12% from other businesses [1] - As of the report date, Jianye Co., Ltd. has a market capitalization of 4.1 billion yuan [1] Group 2 - The article mentions that the Chinese innovative drug sector has sold overseas authorizations worth 80 billion USD this year [1] - It highlights a conversation with Lu Gang, a partner at Chuangdong Investment, discussing the hot secondary market in biomedicine while the primary market faces fundraising challenges [1]

Group 1 - Company Jianye Co., Ltd. reported a revenue of approximately 1.564 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 12.04% [1] - The net profit attributable to shareholders of the listed company was approximately 176 million yuan, showing a year-on-year increase of 5.66% [1] - As of the report date, Jianye Co., Ltd. had a market capitalization of 4.1 billion yuan [2] Group 2 - The Chinese innovative drug sector has achieved overseas licensing sales of 80 billion US dollars this year [2] - The secondary market for biopharmaceuticals is experiencing a surge, while the primary market is facing challenges in fundraising [2]

证券代码：603948 证券简称：建业股份 公告编号：2025-023 特别风险提示 公司使用部分暂时闲置自有资金委托理财购买的为安全性高、流动性好的低 风险投资产品，但金融市场受宏观经济、财政及货币政策的影响较大，不排除该 项投资可能受到市场波动的影响。 一、投资情况概述 （一）投资目的 关于浙江建业化工股份有限公司委托理财的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 基本情况 | 投资金额 | 不超过 万元 | 100,000 | | --- | --- | --- | | 投资种类 | 安全性高、流动性好的低风险投资产品 | | | 资金来源 | 自有资金 | | 已履行的审议程序 公司于 2025 年 10 月 24 日召开第五届董事会第十四次会议、第五届监事会 第十三次会议，分别审议通过了《关于使用部分闲置自有资金委托理财的议案》。 该议案无需提交公司股东大会审议。 为充分利用闲置资金、提高资金使用效率，在保证公司正常经营且资金安全 的情况下，合理利用部分暂时闲置自有资金委托理财，可以增加收 ...

证券代码：603948 证券简称：建业股份 公告编号：2025－022 浙江建业化工股份有限公司 第五届监事会第十三次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、会议召开情况 浙江建业化工股份有限公司（以下简称"公司"）监事会于2025年10月14日向 全体监事以专人送出、邮递或通讯方式发出第五届监事会第十三次会议通知和材 料 。 本次会议于2025年10月24日在公司会议室召开。本次会议应到监事3名，实到 监事3名。会议由公司监事会主席顾海燕女士主持，会议的召集和召开符合《公司 法》等法律、法规及《公司章程》的规定，会议及通过的决议合法有效。 二、会议审议的情况 表决结果：同意 3 票，反对 0 票，弃权 0 票。 具体内容详见公司于 2025 年 10 月 25 日在上海证券交易所网站披露的《浙江 建业化工股份有限公司 2025 年第三季度报告》。 2、审议并通过《关于使用部分闲置自有资金委托理财的议案》 1 监事会认为：本次使用部分闲置自有资金委托理财，是在不影响公司日常经营 和保证资金安全的 ...